ETODOLAC

Generic: ETODOLAC

TaSun Pharmaceutical IndustriesManufacturer
ORALRoute
ETODOLACActive Substance
2003-03-13Original Approval

ETODOLAC is FDA application ANDA076174, sponsored by TARO. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INEFFECTIVE
368 reports
2
PAIN
354 reports
3
NAUSEA
294 reports
4
ARTHRALGIA
287 reports
5
FATIGUE
281 reports
6
HEADACHE
243 reports
7
DIARRHOEA
236 reports
8
DYSPNOEA
225 reports
9
DIZZINESS
209 reports
10
RASH
205 reports